Enanta Pharmaceuticals, Inc. (ENTA) vs Orchestra BioMed Holdings, Inc. (OBIO)
Enanta Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are both Biotechnology companies. Enanta Pharmaceuticals, Inc. and Orchestra BioMed Holdings, Inc. are of similar size ($366.0M and $349.5M). Orchestra BioMed Holdings, Inc. grew revenue faster over the last twelve months: 986.1% against 0.70%. Enanta Pharmaceuticals, Inc. has the higher net margin (−96.9% vs −186.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Enanta Pharmaceuticals, Inc. leads on 11 and Orchestra BioMed Holdings, Inc. on 5.
Valuation
Profitability
| Metric | ENTA | OBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 99.51% | 65.16% |
| Operating margin | (89.99%) | (181.36%) | 0.00% |
| Net margin | (96.89%) | (186.30%) | 0.00% |
| Free cash flow margin | (56.60%) | (184.83%) | 0.00% |
| Return on equity | (70.12%) | (607.32%) | (57.72%) |
| Return on assets | (21.15%) | (75.16%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack